Back
Oramed Pharmaceuticals Stock Predictions
Sponsored
ORMP
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.38
Seasonality Move:
6.43%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.Oramed Pharmaceuticals Stock Forecast
-
Is Oramed Pharmaceuticals Stock Undervalued?The current Oramed Pharmaceuticals [ORMP] share price is $2.38. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Oramed Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Oramed Pharmaceuticals Stock Rating
Data Unavailable
Oramed Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
oramed.com
52-Week Data
52-Week High:
3.67
52-Week Low:
2.00
Prediction Charts
Market Cap:
95.9M
Price in USD:
2.38
Volume:
100.5K
Beta:
1.14
Technical Analysis
SMA50:
2.38
SMA100:
2.38
SMA200:
2.43
52-Wk Change:
8.68%
Stock Predictions
-
Is Oramed Pharmaceuticals stock public?Yes, Oramed Pharmaceuticals is a publicly traded company.
-
What is the Oramed Pharmaceuticals stock quote today?The Oramed Pharmaceuticals stock price is 2.38 USD today.
-
How to buy Oramed Pharmaceuticals stock online?You can buy Oramed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-3 | 2.46 | 2.46 | 2.65 | 2.46 |
Dec-4 | 2.44 | 2.52 | 2.58 | 2.44 |
Dec-5 | 2.51 | 2.51 | 2.61 | 2.49 |
Dec-6 | 2.49 | 2.40 | 2.51 | 2.37 |
Dec-9 | 2.41 | 2.52 | 2.52 | 2.41 |
Dec-10 | 2.52 | 2.51 | 2.56 | 2.49 |
Dec-11 | 2.50 | 2.46 | 2.50 | 2.43 |
Dec-12 | 2.45 | 2.49 | 2.49 | 2.44 |
Dec-13 | 2.49 | 2.47 | 2.49 | 2.45 |
Dec-16 | 2.50 | 2.39 | 2.51 | 2.37 |
Dec-17 | 2.37 | 2.35 | 2.41 | 2.31 |
Dec-18 | 2.35 | 2.40 | 2.50 | 2.35 |
Dec-19 | 2.38 | 2.49 | 2.51 | 2.38 |
Dec-20 | 2.48 | 2.38 | 2.49 | 2.37 |
Oramed Pharmaceuticals Earnings
Data Unavailable
Oramed Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.